Rojkjaer Lisa — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Rojkjaer Lisa has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Rojkjaer Lisa

Lisa Rojkjaer is the Executive Vice President and Chief Medical Officer at Rigel Pharmaceuticals Inc, a company focused on developing small-molecule drugs for various diseases. She has a background in medicine and drug development, contributing to the company's clinical strategies.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-03RIGLRIGEL PHARMACEUTICALS INCF — Tax withholding / forfeiture850$29.86$25K
2026-02-19RIGLRIGEL PHARMACEUTICALS INCA — Grant or award18.9K$0.00
2026-02-12RIGLRIGEL PHARMACEUTICALS INCF — Tax withholding / forfeiture3.8K$34.62$130K

Companies — Last 90 Days

Frequently Asked Questions

Who is Rojkjaer Lisa?

Lisa Rojkjaer is the Executive Vice President and Chief Medical Officer at Rigel Pharmaceuticals Inc, a company focused on developing small-molecule drugs for various diseases. She has a background in medicine and drug development, contributing to the company's clinical strategies.…

How many SEC Form 4 filings has Rojkjaer Lisa submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Rojkjaer Lisa's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Rojkjaer Lisa profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.